Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4459)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2023 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jeeyavudeen MS, Chaudhari R, Pappachan JM, Fouda S. Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease. World J Gastroenterol 2023; 29(3): 487-502 [PMID: 36688018 DOI: 10.3748/wjg.v29.i3.487] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v29/i3/487.htm |
| Number | Citing Articles |
| 1 |
Thomas Grewal, Christa Buechler. Adipokines as Diagnostic and Prognostic Markers for the Severity of COVID-19. Biomedicines 2023; 11(5): 1302 doi: 10.3390/biomedicines11051302
|
| 2 |
Mandal Avishek. Prospective Coronavirus Liver Effects: Available Knowledge. Annals of Clinical Gastroenterology and Hepatology 2023; 7(1): 001 doi: 10.29328/journal.acgh.1001039
|
| 3 |
Caterina Conte, Elisa Cipponeri, Michael Roden. Diabetes Mellitus, Energy Metabolism, and COVID-19. Endocrine Reviews 2024; 45(2): 281 doi: 10.1210/endrev/bnad032
|
| 4 |
Leonidas Brilakis, Eirini Theofilogiannakou, Panagis M Lykoudis. Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19. World Journal of Gastroenterology 2024; 30(11): 1480-1487 doi: 10.3748/wjg.v30.i11.1480
|